Kategori: Press

Steven Glazer joins Inprother as Medical Advisor

Steven Glazer has many years of international experience in healthcare and biotechnology. He has held a number of senior positions within pharmaceutical and bioengineering companies in Europe and the US, including Novo Nordisk, Zealand Pharma, BioInvent International and  Hansa Medical, and has gained deep knowledge…

Mathias Kroll joins InProTher as the new CEO

InProTher is very proud to annnounce that we have hired Mathias Kroll as the company’s new CEO. Mathias Kroll has got twelve years of research experience, split between the academic and biopharmaceutical sectors, and fourteen years of commercial experience mostly from business development but also…

Inprother research published in Oncotarget

We are very happy to announce that a new scientic article by the Inprother-team has been accepted in the Oncotarget journal. The article: “Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice by Lasse Neukirch, Tea Kirkegaard Nielsen, Henriette Laursen, Joana…

WordPress Theme built by Shufflehound.